QIAGEN N.V.(QGEN)Stock Analysis

QGEN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for QIAGEN N.V. (QGEN), a Healthcare sector company. QGEN is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), QIAGEN N.V. reports quarterly revenue of $2.1B, net income of $424.9M, an operating margin of 22.3%. Top institutional holders of QGEN by reported 13-F value include WELLINGTON MANAGEMENT GROUP LLP, VANGUARD CAPITAL MANAGEMENT, DEUTSCHE BANK AG\, based on the most recent SEC filings. QGEN trades on the NYSE exchange and files with the SEC under CIK 1015820. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for QIAGEN N.V. directly from SEC EDGAR.